Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc.（DNA）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
dna · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$12.00
Consensus
$7.84
-4.8% upside
Low
$4.35
Median: $7.5 · Last Close: $8.23
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$7.84
-4.8% upside
High Target
$12
45.7%
Low Target
$4.35
-47.2%
Current Price
$8.23
as of today
Based on analyst price targets, the DNA stock price prediction for the next 12 months ranges from $4.35 to $12. The consensus DNA price forecast of $7.84 implies -4.8% upside from the current price of $8.23.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.40 | ↑ 2.05% |
1-day model range: $8.31–$8.5. Peak: $8.5 (+2.05%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -63.7% |
| 2029 | $3 | -69.2% |
| 2030 | $2 | -71.8% |
| 2031 | — | -73.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DNA · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-12 | BTIG | Maintains | Sell→Sell |
| 2026-01-08 | TD Cowen | Maintains | Buy→Buy |
| 2025-08-25 | BTIG | Maintains | Sell→Sell |
| 2024-09-20 | TD Cowen | Maintains | Buy→Buy |
| 2024-08-23 | BTIG | Maintains | Sell→Sell |
| 2024-07-09 | Goldman Sachs | Maintains | Sell→Sell |
| 2024-06-26 | BTIG | Maintains | Sell→Sell |
| 2024-05-15 | BTIG | Downgrade ↓ | Neutral→Sell |
| 2024-05-15 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2024-05-10 | William Blair | Downgrade ↓ | Market Perform→Underperform |
Wall Street analysts have recently issued updated ratings on Ginkgo Bioworks Holdings, Inc. (DNA) stock. Of the recent 33 rating actions, 0 were upgrades and 8 were downgrades. 11 analysts currently cover DNA.
分析师推荐趋势
DNA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$174M
↑ 32.8% YoY
Revenue Next Year
$123M
↓ 29.2% YoY
EPS This Year
$-5.64
EPS Next Year
$-4.33
↓ 23.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast DNA EPS of $-5.64 for the current fiscal year, based on estimates from 1 analysts. The DNA revenue forecast is $174M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
DNA 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。DNA 的共识目标价为 $7.84（-4.8% 上行空间），分析师共识为 Buy。
DNA 的短期预测（明日）为 $8.40（+2.05%）。 DNA 对 2027 年的股价预测均值为 $4。 DNA 对 2030 年的预测区间为 $2–$3。
Ginkgo Bioworks Holdings, Inc. 在 NYSE 上市，代码 DNA。DNA 在 2027 年的整体展望偏积极，在覆盖分析师中约 45% 对应 Buy 共识。
常见问题
DNA 预测 · 8 个问题根据 11 位华尔街分析师，DNA 的 12 个月平均目标价为 $7.84，最高 $12.00、最低 $4.35。若有图表，中位目标价可在上方查看。相对当前价 $8.23，隐含约 -4.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.